Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer

MSK high-sensitivity cfDNA sequencing: baseline or postsurgical ctDNA was associated with reduced PFS; in 6 patients with recurrence, ctDNA fraction tracked disease and therapy response, with a lead time in two cases.

Clin Cancer ResPubMed 36007103DOI 10.1158/1078-0432.CCR-22-1134